九安医疗: 第六届董事会第二十五次会议决议公告

Group 1 - The company held its 25th meeting of the 6th Board of Directors on September 5, 2025, with all 6 directors present, complying with legal and statutory requirements [1][2] - The Board approved a proposal to change the purpose of 9,771,882 shares originally intended for maintaining company value and shareholder rights to be used for cancellation and reduction of registered capital [1][2] - The proposal for share cancellation requires approval from the shareholders' meeting, and the Board has requested authorization for management to handle the related procedures [2] Group 2 - The company plans to hold its third extraordinary shareholders' meeting on September 22, 2025, combining in-person and online voting [2]